Oxford BioMedica PLC Interim Results for the Six Months Ended 30 June 2007

September 12, 2007 |

1 min read

Oxford BioMedica (LSE: OXB), a leading gene therapy company, announced today its interim financial results for the six months ended 30 June 2007. Year to date highlights

Earnings Europe

MORE ON THIS TOPIC

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Vertex Terminates 20 in Reorganization Push

March 9, 2026

·

32 min read

·

BioSpace Editorial Staff

Brain tumor medical poster. Cancer, metastasis or benign in the human head or in the nerves, pituitary gland, pineal gland, and membranes that cover the surface of the brain 3D vector illustration

Mergers & acquisitions

Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy

March 6, 2026

·

1 min read

·

Annalee Armstrong

Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.

Cardiovascular disease

Alnylam Unites With Tenaya in Potential $1B+ Pact To Find New Genetic Heart Disease Targets

March 5, 2026

·

2 min read

·

Heather McKenzie

Modern design with a positive context, a handshake. Concept of help, support and harmony between adults. Modern art collage, trendy magazine style.

Collaboration

Roche Broadens Global Clinical Trial Footprint With $480M+ South Korea Pledge

March 5, 2026

·

1 min read

·

Tristan Manalac